Literature DB >> 19959026

Cancer genesis across the age spectrum: associations with tissue development, maintenance, and senescence.

Philip Rubin1, Jacqueline P Williams, Susan S Devesa, Lois B Travis, Louis S Constine.   

Abstract

Cancer genesis across the age spectrum is a complex, multifactorial process, and parallels changes in site-specific tissue development, maintenance, and senescence. Cancer is not a single disease, and different tumor and stem cells may demonstrate various manifestations of abnormal function. Mutations in DNA, some random and some explained by exogenous insults, accompanied by changes in the tissue microenvironment, generally precede the onset of aberrant replication and apoptosis. Moreover, increasing evidence suggests that genetic programs normally active only during development of human beings may be reactivated during tumorigenesis. The complicated underlying biology of human growth, development, and carcinogenesis is reflected in the highly disparate patterns in site-specific cancer incidence rates across age groups. In childhood, the peak years of an organ system's increase in size correlate with peak years of cancer incidence. Conversely, in most adult-onset cancers, it is exposure to exogenous toxins, the failure of maintenance and repair, and finally, dysfunction(s) in the normal cellular aging process that likely play a role in the development of these malignancies. Additional basic science investigations and epidemiologic studies will assist in our understanding of the mechanisms that underlie the notable difference in site-specific cancer incidence according to age.

Entities:  

Mesh:

Year:  2010        PMID: 19959026     DOI: 10.1016/j.semradonc.2009.08.001

Source DB:  PubMed          Journal:  Semin Radiat Oncol        ISSN: 1053-4296            Impact factor:   5.934


  6 in total

Review 1.  The circadian clock in cancer development and therapy.

Authors:  Loning Fu; Nicole M Kettner
Journal:  Prog Mol Biol Transl Sci       Date:  2013       Impact factor: 3.622

2.  Demographic variation in incidence of adult glioma by subtype, United States, 1992-2007.

Authors:  Robert Dubrow; Amy S Darefsky
Journal:  BMC Cancer       Date:  2011-07-29       Impact factor: 4.430

3.  The growth and aggressive behavior of human osteosarcoma is regulated by a CaMKII-controlled autocrine VEGF signaling mechanism.

Authors:  Paul G Daft; Yang Yang; Dobrawa Napierala; Majd Zayzafoon
Journal:  PLoS One       Date:  2015-04-10       Impact factor: 3.240

4.  Independent Pre-Transplant Recipient Cancer Risk Factors after Kidney Transplantation and the Utility of G-Chart Analysis for Clinical Process Control.

Authors:  Harald Schrem; Valentin Schneider; Marlene Kurok; Alon Goldis; Maren Dreier; Alexander Kaltenborn; Wilfried Gwinner; Marc Barthold; Jan Liebeneiner; Markus Winny; Jürgen Klempnauer; Moritz Kleine
Journal:  PLoS One       Date:  2016-07-11       Impact factor: 3.240

5.  Characterization of transcriptome diversity and in vitro behavior of primary human high-risk breast cells.

Authors:  Sahar J Alothman; Keunsoo Kang; Xuefeng Liu; Ewa Krawczyk; Redha I Azhar; Rong Hu; David Goerlitz; Bhaskar V Kallakury; Priscilla A Furth
Journal:  Sci Rep       Date:  2022-04-22       Impact factor: 4.996

6.  Prognostic Nomograms for Primary High-Grade Glioma Patients in Adult: A Retrospective Study Based on the SEER Database.

Authors:  Yi Yang; Mingze Yao; Shengrong Long; Chengran Xu; Lun Li; Yinghui Li; Guangyu Li
Journal:  Biomed Res Int       Date:  2020-07-23       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.